Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Small Cell Lung Carcinoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Lung Neoplasms 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Methotrexate 29Cytarabine 28Vincristine 26Cyclophosphamide 25Mercaptopurine 20Dexamethasone 20pegaspargase 18Prednisone 17Doxorubicin 17Daunorubicin 16Asparaginase 15merphos 14Calcium Dobesilate 14Thioguanine 13Leucovorin 13Radiotherapy 11Hydrocortisone 10azathiopurine 9Filgrastim 9Etoposide 9Granulocyte Colony-Stimulating Factor 8dexamethasone acetate 7dexamethasone 21-phosphate 7auricularum 7Specimen Handling 7prednylidene 6deltacortene 6Whole-Body Irradiation 6Methylprednisolone 6fludarabine phosphate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Introns × Clear all
NCT00002621 2014-07-24

Interferon Alfa in Treating Children With HIV-Related Cancer

Children's Oncology Group

Phase 2 Completed
8 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡